Introduction of QIAGEN's RespiFinder RG Panel: The Portsmouth experience


Acute respiratory tract infection is the most widespread type of acute infection in adults and children and is a significant cause of mortality in immunocompromised patients. The RespiFinder RG Panel is a multiplex PCR assay for the simultaneous detection and differentiation of 21 respiratory pathogens within 4 hours, with the same sensitivity and specificity as monoplex real-time PCR.

Sensitive and comprehensive detection of the causative pathogen(s) can now be achieved within a single working day. The webinar gives the user’s experience of the effects of fast and sensitive results on therapy and the prevention of unnecessary use of antibiotics or hospital admissions.


Allyson J Lloyd

Allyson J Lloyd started her Medical Microbiology career in July 1986, at the Public Health Laboratory at St Mary’s Hospital in Portsmouth. After three years training and attainment of a HNC in Medical Microbiology, she became a registered Medical Laboratory Scientific Officer in 1989. Her focus for the next ten years was predominately diagnostic virology. Following a laboratory re-organization in 1999, she became proficient in bacteriology as well. In 2002, she obtained a Senior Supervisory position and a Master’s degree in Biomedical Science. From 2010 to the present, she has been responsible for the molecular diagnostic service provided by the laboratory.